FDA recall D-1359-2016
Hospira Inc. · Class II · drug
Product
Diazepam Injection USP 10mg/2mL (5 mg/mL, 2 mL), Rx only, Hospira Inc. Lake Forest, IL 60045, NDC 0409-1273-32
Reason for recall
Crystallization: Product contains particulate identified to be crystallized active ingredient.
Distribution
Nationwide
Key facts
- Status
- Terminated
- Initiation date
- 2016-06-23
- Report date
- 2016-07-20
- Termination date
- 2018-08-31
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Lake Forest, IL, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1359-2016